drugset / Trial / NCT00972816
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)
RandomizedParallel-groupSingle-blindPrevention
Summary
This study will evaluate the safety and immunogenicity of different combinations of A/H1N1 S-OIV (swine flu) vaccine in healthy young children.
Timeline
- Start
- 2009-09
- Primary completion
- 2009-11
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MF59-eH1N1 | Vaccine | 3.75 ug | — |
| Subject | MF59-eH1N1 | Vaccine | 7.5 ug | — |
| Subject | MF59-eH1N1 | Vaccine | 15 ug | — |
| Subject | MF59-eH1N1 | Vaccine | 30 ug | — |